Global Robotics Institute, Florida Hospital-Celebration Health, University of Central Florida School of Medicine, Celebration, Florida, USA.
J Endourol. 2011 Jun;25(6):1013-9. doi: 10.1089/end.2010.0564. Epub 2011 May 13.
Open radical prostatectomy after radiation treatment failure for prostate cancer is associated with significant morbidity. The purpose of the study is to report multi-institutional experiences while performing salvage robot-assisted radical prostatectomy (sRARP).
We retrospectively identified 15 patients with biopsy-proven prostate cancer after definitive radiotherapy who underwent sRARP in three academic institutions over a 20-month period. Continence was defined as the use of 0 pads after surgery. Potency was defined as the ability to achieve erections adequate enough for penetration with or without the use of phosphodiesterase-5 inhibitors. Biochemical recurrence after sRARP was defined as a prostate-specific antigen value of >0.2 ng/mL.
Radiation treatment consisted of external-beam radiation therapy (XRT) in five cases, interstitial radioactive 125-iodine brachytherapy (BT) in five cases, proton beam therapy in two cases, and XRT followed by interstitial radioactive 125-iodine BT in three cases. The median operative time, the median estimated blood loss, and the median length of hospital stay were 140.5 min (interquartile range [IQR] 97.5-157 min), 75 mL (IQR 50-100 mL), and 1 day (IQR 1-2 d), respectively. There were no rectal injuries. Two (13.3%) patients had a positive surgical margin. A total of three (20%) patients had postoperative complications. One patient had a deep vein thrombosis (Clavien grade II), one had wound infection (Clavien grade II), and one patient had an anastomotic leak (Clavien gradeId). An anastomotic stricture (Clavien grade IIIa) later developed in this same patient, which was managed by direct visual internal urethrotomy. Of the patients, 71.4% were continent. At a median follow-up of 4.6 months (IQR 3-9.75 mos), four (28.6%) patients presented with biochemical recurrence after sRARP.
The challenge during sRALP is the presence of extensive fibrosis and loss of dissection planes secondary to radiation therapy. It is a technically challenging but feasible procedure. The early complication rates were low, and early continence rates are encouraging.
对于前列腺癌患者,在放射治疗失败后行开放性根治性前列腺切除术与显著的发病率相关。本研究的目的是报告在三个学术机构进行挽救性机器人辅助根治性前列腺切除术(sRARP)的多机构经验。
我们回顾性地确定了在 20 个月期间在三个学术机构中接受 sRARP 的 15 例经活检证实为前列腺癌且接受过确定性放射治疗的患者。控尿定义为术后使用 0 片尿垫。勃起功能定义为能够进行足够勃起以进行插入,无论是否使用磷酸二酯酶-5 抑制剂。sRARP 后生化复发定义为前列腺特异性抗原值>0.2ng/ml。
放射治疗包括 5 例外照射放疗(XRT)、5 例放射性 125 碘粒子间质内放疗(BT)、2 例质子束放疗和 3 例 XRT 后放射性 125 碘 BT。中位手术时间、中位估计出血量和中位住院时间分别为 140.5 分钟(四分位距 [IQR] 97.5-157 分钟)、75 毫升(IQR 50-100 毫升)和 1 天(IQR 1-2 天)。无直肠损伤。2 例(13.3%)患者切缘阳性。共 3 例(20%)患者发生术后并发症。1 例发生深静脉血栓形成(Clavien Ⅱ级),1 例发生伤口感染(Clavien Ⅱ级),1 例发生吻合口漏(Clavien Ⅰ级)。同一位患者随后发生吻合口狭窄(Clavien Ⅲa 级),经直接可视尿道内切开术治疗。10 例患者中有 71.4%有控尿能力。在中位随访 4.6 个月(IQR 3-9.75 个月)时,4 例(28.6%)患者在 sRARP 后出现生化复发。
在 sRALP 中,由于放射治疗导致广泛纤维化和解剖平面丢失,手术具有挑战性。它是一种具有挑战性但可行的手术。早期并发症发生率低,早期控尿率令人鼓舞。